Texan Capital Management’s GSK GSK Stock Holding History

Texan Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,734	Closed	-$202K	–	137
2016 Q2	$202K	Sell	3,734 -1,530	-29%	-$80.6K	0.09%	129
2016 Q1	$268K	Buy	5,264 +160	+3%	+$7.97K	0.13%	122
2015 Q4	$257K	Hold	5,104	–	–	0.12%	127
2015 Q3	$245K	Buy	+5,104	New	+$266K	0.11%	129
2015 Q2	–	Sell	-3,816	Closed	-$220K	–	147
2015 Q1	$220K	Hold	3,816	–	–	0.12%	114
2014 Q4	$204K	Hold	3,816	–	–	0.09%	122
2014 Q3	$219K	Hold	3,816	–	–	0.09%	121
2014 Q2	$255K	Hold	3,816	–	–	0.11%	124
2014 Q1	$255K	Sell	3,816 -12,076	-76%	-$816K	0.12%	130
2013 Q4	$1.06M	Buy	15,892 +6,192	+64%	+$401K	0.54%	59
2013 Q3	$608K	Sell	9,700 -160	-2%	-$10.3K	0.29%	94
2013 Q2	$616K	Buy	+9,860	New	+$626K	0.3%	97

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Texan Capital Management's GSK Position: Q3 2016 in Review

Texan Capital Management sold out of GSK (GSK) in Q3 2016, closing a stake of 3,734 shares — an estimated $202K sold.

Texan Capital Management first reported a position in GSK in Q2 2013 and held it in 12 quarters. The position peaked at $1.06M in Q4 2013. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

Texan Capital Management reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
Texan Capital Management sold 3,734 GSK shares in Q3 2016, an estimated $202K.
Texan Capital Management first reported a position in GSK in Q2 2013 and held it in 12 quarters.
Texan Capital Management's GSK position peaked at $1.06M in Q4 2013.
741 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Texan Capital Management's 13F filing for Q3 2016, filed 2 Nov 2016.